|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0350 - 0.0350|
|52 Week Range||0.0320 - 0.6000|
|Beta (5Y Monthly)||2.80|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Medivolve Inc. ("Medivolve" or the "Company") (NEO: MEDV) (FRA: 4NC) is pleased to announce the Company has closed the previously announced secured convertible note (the "Notes") financing for aggregate gross proceeds to the Company of CAN $1.2 million (the "Offering"). The Notes have a term of 24 months and are convertible into an aggregate of up to 17,142,857 units (the "Units") at a price per Unit of $0.07.
Medivolve Inc. ("Medivolve" or the "Company") (NEO: MEDV) (FRA: 4NC), a healthcare technology and services company, today announced a secured convertible note financing in the amount of up to CAN $1.2 million and an equity private placement in the amount of up to CAN $1.4 million.
Medivolve, Inc. ("Medivolve" or the "Company") (NEO: MEDV) (OTC: COPRF) (FRA: 4NC) today announced it will launch its first two mobile COVID-19 testing vans servicing Las Vegas, Nevada and surrounding areas.